Medical Advocates
HAART/ART
/cART
  Adverse Events
 
General Reports
Autoimmune Disease
Blood/Lymphatic
Cardiovascular  
Cutaneous 
Eye  
 
Genitourinary
GI
IRIS
Mental Health
Metabolic 
Musculoskeletal
Neurological

Oral
Oncological
Pancreatic  
Endocrine

Hepatic
Respiratory
 
   

HAART Main Page Main New/Newsworthy  Home Page

Last Update:  April 21, 2018  
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader


General/Miscellaneous Reports

 

          Journal Papers, Abstracts, and Commentaries
 
 
FU:LL-TEXT ARTICLE
Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)[Germany]
Dold L, Luda C, Schwarze-Zander C, et al
PLoS One. 2017 Jun 8;12(6):e0178685.
Paper

Fluticasone furoate induced iatrogenic Cushing syndrome in a pediatric patient receiving anti-retroviral therapy.
van den Berg SAA, van 't Veer NE, Emmen JMA, van Beek RHT.
Endocrinol Diabetes Metab Case Rep
. 2017 Apr 6;2017.
Abstract

Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV-Positive Patients in Imam Khomeini Hospital of Tehran, Iran.
Golrokhy R, Koochak HE, Babaii A, et al
Infect Disord Drug Targets
. 2017 Jan 17
Abstract

Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients.
Tetteh RA, Nartey ET, Lartey M, et al 
Drug Saf
. 2016 Sep 15.
Abstract

The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis.
Li H, Marley G, Ma W,
AIDS Behav
.
2016 Sep 9. 
Abstract

Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
Mouton JP, Cohen K, Maartens G.
Expert Rev Clin Pharmacol
. 2016 Aug 6
Abstract

Effect of Antiretroviral Therapy on Circulating Damage-Associated Molecular Pattern Molecules (DAMPs) and CD4 Immune Reconstitution in HIV-Infected Individuals
Drozd D, Graham S, Crane H, et al
AIDS Res Hum Retroviruses
. 2016 May 11

Abstract

Side effects, adherence self-efficacy, and adherence to antiretroviral treatment: a mediation analysis in a Chinese sample.
Zhang L, Li X, Lin Z,  et al
AIDS Care
. 2016 Mar 24:1-8.
Abstract

Self-reported adherence to antiretroviral therapy in HIV+ population from Bata, Equatorial Guinea.
Salmanton-García J, Herrador Z, Ruiz-Seco P, et al
AIDS Care
. 2015 Dec 24:1-11
Abstract

FULL-TEXT ARTICLE
HIV patients stable on ART retain evidence of a high CMV load but changes to Natural Killer cell phenotypes reflect both HIV and CMV.
Affandi JS, Montgomery J, Lee S, Price P.

AIDS Res Ther
. 2015 Dec 9;12:41
Paper

Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy.
Conley LJ, Bush TJ, Rupert AW, et al

AIDS
. 2015 Oct 23;29(16):2201-2207.
Abstract

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.
Overton ET, Chan ES, Brown TT,  et al
Ann Intern Med. 2015 Jun 16;

Abstract

Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.
Erlandson KM, O'Riordan M, Hileman CO, et al
 
AIDS Res Hum Retroviruses
. 2015 Apr 28.
Abstract

A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy.
Claborn KR, Meier E, Miller MB, Leffingwell TR.
Psychol Health Med
. 2014 Aug 11:1-11.
Abstract

Severe or life-threatening interactions between antiretrovirals and non-HIV drugs.
Manzardo C, Tuset M, Miró JM, Gatell JM.
Enferm Infecc Microbiol Clin
. 2014 Jun 6.
Abstract

FULL-TEXT PDF ARTICLE
CROI 2014: viral hepatitis and complications of HIV disease and antiretroviral therapy.
Luetkemeyer AF, Havlir DV, Currier JS
Top Antivir Med
. 2014 May;22(2):602-15.
Paper

FULL-TEXT ARTICLE
Influence of Adverse Drug Reactions on Treatment Success: Prospective Cohort Analysis of HIV-Infected Individuals Initiating First-Line
Antiretroviral Therapy in India.
Shet A, Antony J, Arumugam K,  et al
PLoS One. 2014 Mar 10;9(3):e91028
Paper

FULL-TEXT ARTICLE
Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management.
Yunihastuti E, Widhani A, Karjadi TH.
Asia Pac Allergy. 2014 Jan;4(1):54-67.
Paper

Can early therapy reduce inflammation?
Sandler NG, Sereti I.
Curr Opin HIV AIDS. 2013 Nov 15.
Abstract

Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy.
Fourati S, Flandre P, Calin R, Carcelain G,  et al
J
Antimicrob Chemother
. 2013 Nov 1
Abstract

Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes.
Kumar S, Jin M, Ande A, et al

Expert Opin Drug Metab Toxicol
. 2012 Aug 8.
Abstract

Antiretroviral Therapy (ART) Side Effect Impacted on Quality of Life, and Depressive Symptomatology: A Mixed-Method Study.
Chen WT, Shiu CS, Yang JP, et al
J AIDS Clin Res. 2013 Jun 29;4:218..
Abstract
 

Fatal cumulative toxicities of HAART in a stable, AIDS-free, HIV-infected patient.
Saison J, Cotte L, Chidiac C, Ferry T.
BMJ Case Rep. 2012 Mar 8;2012
Abstract

Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications.
Blas-Garcia A, Apostolova N, Esplugues JV.
Curr Pharm Des. 2011 Dec 1;17(36):4076-86..
Abstract

Long term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort.
Van Lelyveld SF, Gras L, Kesselring A, et al

AIDS
. 2011 Nov 22.
Abstract

A Frailty-Related Phenotype Before HAART Initiation as an Independent Risk Factor for AIDS or Death After HAART Among HIV-Infected Men.
Desquilbet L, Jacobson LP, Fried LP

J Gerontol A Biol Sci Med Sci
. 2011 Jun 30
Abstract

Common Adverse Effects of Antiretroviral Therapy for HIV Disease.
Reust CE.
Am Fam Physician. 2011 Jun 15;83(12):1443-51
Abstract

Additive Effects of Numbness and Muscle Aches on Fatigue Occurrence in Individuals with HIV/AIDS Who Are Taking Antiretroviral Therapy.
Wantland DJ, Mullan JP, Holzemer WL,  et al J
Pain Symptom Manage
. 2011 Jan 12.
Abstract

FULL-TEXT ARTICLE
Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy.
Bellistrì GM, Casabianca A, Merlini E,  et al

PLoS One
. 2010 Dec 31;5(12):e15663
Paper

Taking Side-Effects into Account for HIV Medication.
Costanza V, Rivadeneira P, Biafore F, D'Attellis C.

IEEE Trans Biomed Eng
. 2010 May 24
Abstract

Clinical and Demographic Variables Related to Pain in HIV-Infected Individuals Treated with Effective, Combination Antiretroviral Therapy (cART).
Cervia LD, McGowan JP, Weseley AJ
Pain Med. 2010 Mar 4.
Abstract

Effect of combination antiretroviral treatment on total protein and calculated globulin levels among HIV-infected patients.
Serpa J, Haque D, Valayam J, et al

Int J Infect Dis
. 2010 Feb 3.
Abstract
 

        Conference Reports, Abstracts, and Posters
 
 
Risk factors for mortality among HIV positive patients on HAART at Mildmay Uganda
R. Nakigudde
(XX International AIDS Conference)
Abstract

Increased risk of serious non-AIDS defining events and mortality among immunological non-responders to antiretroviral therapy in the Italian MASTER cohort
G. Lapadula, L. Chateneaud, A. Gori, et al.
(
XIX International AIDS Conference)
Abstract

cART did not prevent new severe non-AIDS events in patients with a low nadir CD4 T cell count and a baseline CD4 T cell count above 500 cells/mm3
B. Torres, C. Lucero, A. León, M. Calvo

(XIX International AIDS Conference)
Abstract


Blood/Lymphatic Disorders

                    

Anemia
 
          Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen.
Takuva S, Maskew M, Brennan AT,  et al

J Trop Med
. 2013;2013:162950.

Paper
 
Dyslipidemia
 
          Journal Papers, Abstracts, and Commentaries
 
  Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: A systematic review and meta-analysis.
Nduka C, Sarki A, Uthman O, Stranges S.

Int J Cardiol
. 2015 Jul 23;199:307-318. 
Abstract

Endothelial Activation

 
          Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy.
Rönsholt FF, Ullum H, Katzenstein TL,  et al
PLoS One. 2013 Jun 3;8(6):e65182
.
Paper

Hyperbilirubinemia

          Journal Papers, Abstracts, and Commentaries

  Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia.
Rotger M, Taffe P, Bleiber G, et al
J Infect Dis. 2005 Oct 15;192(8):1381-
6.
Abstract
 
Hypergammaglobulinaemia

          Journal Papers, Abstracts, and Commentaries
 
  The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.
Redgrave BE, Stone SF, French MA, et al
HIV Med. 2005 Sep;6(5):307-12

Abstract
 

Leukemia

          Journal Papers, Abstracts, and Commentaries
 

  Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass.
Manfredi R, Sabbatani S, Chiodo F. et al
Scand J Infect Dis
. 2005 Oct;37(10):781-783.
Abstract
 
Multicentric Castleman's Disease
 
         Journal Papers, Abstracts, and Commentaries
 
  HIV-associated multicentric Castleman's disease after initiation of antiretroviral therapy: experience of a European centre.
Katchanov J, Zimmermann U, Branding G,  et al
Infection. 2014 Mar 4.
Abstract

Central/Peripheral Nervous System Disorders
 

          Journal Papers, Abstracts, and Commentaries

  Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
Vendrely A, Bienvenu B, Gasnault J, et al
Acta Neuropathol (Berl). 2005 Mar 1;
Abstract

Cutaneous and Integumentary System Disorders
 

General Reports
 
         Journal Papers, Abstracts, and Commentaries
 
  Cutaneous toxicities of antiretroviral therapy for HIV Part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors.
Introcaso CE, Hines JM, Kovarik CL.

J Am Acad Dermatol
. 2010 Oct;63(4):549-561
Abstract
 
Cutaneous toxicities of antiretroviral therapy for HIV Part II. Nonnucleoside reverse transcriptase inhibitors, entry and fusion inhibitors, integrase inhibitors, and immune reconstitution syndrome.
Introcaso CE, Hines JM, Kovarik CL.

J Am Acad Dermatol
. 2010 Oct;63(4):563-569.
Abstract

Mycoses
 

          Journal Papers, Abstracts, and Commentaries
 
  Increased incidence of cutaneous mycoses after HAART initiation: a benign form of immune reconstitution disease?
Nacher M, Vantilcke V, Mahamat A, et al
AIDS. 2007 Oct;21(16):2248-2250.
Abstract
 
Breast Disorders
 
Breast Abscess
 
          Journal Papers, Abstracts, and Commentaries
 
  Cryptococcal breast abscess in an HIV-positive patient: Arguments for reviewing the definition of immune reconstitution inflammatory syndrome.
Haddow LJ, Sahid F, Moosa MY.
J Infect.
2008 Feb 26
Abstract

Gynecomastia

          Journal Papers, Abstracts, and Commentaries

 
Gynecomastia With Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Associated With Invasive Breast Carcinoma in a Male Patient on Antiretroviral Therapy: A Case Report.
Coyne JD.
Int J Surg Pathol. 2015 Nov 25.
Abstract

Bilateral lipomastia in men: a side effect of highly active antiretroviral therapy.
Deonarain J, Ramdial PK, Singh B.
Int J Surg Pathol. 2008 Apr;16(2):171-5.
Abstract


Eye Disorders
       

          Journal Papers, Abstracts, and Commentaries

  Blepharoptosis and HAART Related Mitochondrial Myopathy.
Chapman KO, Lelli G.

Orbit
. 2014 Sep 12:1-3..
Abstract
 

Mental Health Disorders
 

          Journal Papers, Abstracts, and Commentaries

 
Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs.
Abers MS, Shandera WX, Kass JS
CNS Drugs. 2013 Dec 21.

Abstract

Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs.
Gutiérrez F, García L, Padilla S, et al
HIV Med
. 2013 Nov 11.
Abstract

Depression associated with antiretroviral drug therapy in HIV: case report and overview.
Kaestner F, Anneken K, Mostert C, et al
Int J STD AIDS. 2012 Jun;23(6):e14-9.

Abstract

Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.
Protopopescu C, Raffi F, Brunet-François C, et al

Antivir Ther
. 2012 Apr 27.
Abstract

Psychiatric Risk Factors for HIV Disease Progression: The Role of Inconsistent
Patterns of Antiretroviral Therapy Utilization.
Carrico AW, Riley ED, Johnson MO, et al

J Acquir Immune Defic Syndr
. 2010 Nov 24.
Abstract


Metabolic Disorders
Metabolic Syndrome

          Journal Papers, Abstracts, and Commentaries

 
Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy.
Rodríguez-Gallego E, Gómez J, Domingo P, Ferrando-Martínez S,  et al
Atherosclerosis
. 2018 Apr 9;273:28-36.
Abstract

Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study.
Nuvoli S, Caruana G, Babudieri S, Solinas P
Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):
Abstract

Lower levels of IL-4 and IL-10 influence lipodystrophy in HIV/AIDS patients under antiretroviral therapy.
Dragović G, Dimitrijević B, Khawla AM, et al
Exp Mol Pathol. 2017 Feb 8.
Abstract

Body Fat Changes in People Living with HIV on Antiretroviral Therapy.
Nduka CU, Uthman OA, Kimani PK, Stranges S.
AIDS Rev. 2016 Jul 19;18(4).
Abstract

Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study
Kamara DA, Smith C, Ryom L, Reiss P, et al
Antivir Ther
. 2016 Apr 26.
Abstract

FULL-TEXT ARTICLE
Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities
Ghislain M, Bastard JP, Meyer L, et al
PLoS One. 2015 Dec 4;10(12):e01443
Paper

Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).
Dai Z, Cai W, Hu F, et al  

Curr Mol Med
. 2015;15(10):975-9.
Abstract

Highly Active Antiretroviral Therapy (HAART)-Related Hypertriglyceridemia Is Associated With Failure of Recovery of CD14lowCD16+ Monocyte Subsets in AIDS Patients.
Han J, Zhao H, Ma Y, et al

Medicine
(Baltimore)
. 2015 Jul;94(27):e1115.
Abstract

Case of newly onset type 1 diabetes after highly active antiretroviral therapy against HIV infection.
Kamei S, Kaneto H, Hashiramoto M, et al
J Diabetes Investig. 2015 May;6(3):367-8. .
Abstract

Changes in Body Mass Index Following HAART Initiation among HIV-Infected Women in the Women's Interagency HIV Study.
Sharma A, Bynum SA, Schneider MF,  et al

J AIDS Clin Res
. 2014;5.
Abstract

FULL-TEXT ARTICLE
Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction.
de Waal R, Cohen K, Maartens G.
PLoS One. 2013 May 28;8(5):e63623
Paper

Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review.
Souza SJ, Luzia LA, Santos SS, Rondó PH.

Rev Assoc Med Bras
. 2013 Mar-Apr;59(2):186-98.
Abstract

The development of metabolic risk factors after the initiation of the second line anti- retroviral therapy.
Mittal A, Achappa B, Madi D, et al
J Clin Diagn Res. 2013 Feb;7(2):265-8.
Abstract

Differences in body fat distribution assessed by ultrasonography in patients receiving antiretroviral drugs.
Signorini DJ, Oliveira Netto AM,  

Rev Assoc Med Bras
. 2012 Apr;58(2):197-203.
Abstract

Effects of first antiretroviral regimen on lipid levels in HIV (+) individuals.
Papadopoulos A, Pantazis N, Panagopoulos P,  et al

J Chemother
. 2012;24(1):38-47..|
Abstract

FULL-TEXT PDF ARTICLE
Dyslipidemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the
Spanish VACH cohort.

Estrada V, Geijo P, Fuentes-Ferrer M, et al
 
BMC Womens Healt
h
. 2011 Aug 4;11(1):36
Paper

Switching antiretroviral therapy to minimize metabolic complications.
Lake JE, Currier JS.
HIV Ther. 2010 Nov;4(6):693-711
Abstract

Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients.
Veloso S, Peraire J, Viladés C,  et al

Curr Pharm Des
. 2010 Aug 5
Abstract
 

Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment.
Giralt M, Díaz-Delfín J, Gallego-Escuredo JM,
et al
Curr Pharm Des
. 2010 Aug 5.
Abstract
 
Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on Metabolic Regulations.
Caron-Debarle M, Boccara F, Lagathu C,  et al

Curr Pharm Des
. 2010 Aug 5
Abstract
 
Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances in HIV-1 Infected Patients.
Stankov MV, Behrens GM.

Curr Pharm Des
. 2010 Aug 5.
Abstract

 

          Conference Reports, Abstracts, and Posters
 
  Impact of short-term change in body mass index (BMI) after antiretroviral therapy (ART) initiation on subsequent risk of cardiovascular disease (CVD) and diabetes in HIV-positive individuals: the D:A:D study
A.C. Achhra, A. Mocroft, P. Reiss, et al
(XX
 International AIDS Conference)
Abstract

Incidence rate and risk factors of diabetes mellitus in HIV-1 infected adults on antiretroviral therapy (ART) in Thailand,
P. Riyaten, N. Salvadori, R. Suaysod, et al
(XX
 International AIDS Conference)
Abstract

Understanding lipodystrophy among men and women living with HIV: a metasynthesis of qualitative research
M. Gagnon, L. Cormier
(XIX International AIDS Conference)
Abstract

Hyperlactataemia is a common complication of antiretroviral therapy in children in rural Mopani District, South Africa
M. van Ramshorst, H. Struthers, J.A. McIntyre R.P.H. Peters
(XIX International AIDS Conference)
Abstract

Epidemiological aspect, clinical and psychosocial impact of lipodystrophy related to antiretroviral drugs in people living with HIV followed up at the center of care CRIPS-TOGO in Lome
K.M. Aho, D. Idimama Kotoudi, A. Patassi, B. Saka
(XIX International AIDS Conference)
Abstract



Central and Peripheral Nervous Systems
       

          Journal Papers, Abstracts, and Commentaries

 
Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4).
Melliez H, Mary-Krause M, Bocket L, et al
Clin Infect Dis. 2018 Apr 4
Abstract

Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
Sanford R, Fellows LK, Ances BM, Collins DL.
JAMA Neurol. 2017 Nov 13.
Abstract

HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy.
Bowen LN, Tyagi R,
Li W, et al
Neurology. 2016 Sep 24.
Abstract

Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.
Shah A, Gangwani MR, Chaudhari NS, et al
Neurotox Res
. 2016 Jun 30
Abstract

Meningiomatosis in an AIDS Patient Receiving Highly Active Antiretroviral Therapy (HAART).
Romero CF, Soto-Hernández JL, Bonnet C, Cárdenas G.
Neurologist
. 2016 May;21(3):44-6.
Abstract

Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy.
Schouten J, Su T, Wit FW, et al
AIDS. 2016 Jan 8. 
Abstract

Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Wright E, Grund B, Cysique, et al
HIV Med
. 2015 Apr;16 Suppl S1:97-108.
Abstract

Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen.
Lee AJ, Bosch RJ, Evans SR, et al

J
Neurovirol. 2015 Feb 13.
Abstract

Plasma and cerebrospinal fluid biomarkers predict cerebral injury in HIV-infected individuals on stable combination antiretroviral therapy.
Anderson AM, Harezlak J, Bharti A. et al
 
J Acquir Immune Defic Syndr
. 2015 Jan 23.
Abstract

Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system.
Akay C, Cooper M, Odeleye A,  et al

J Neurovirol
. 2014 Jan 14

Abstract

Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs.
Abers MS, Shandera WX, Kass JS
CNS Drugs. 2013 Dec 21.

Abstract

HIV-associated neurocognitive disorders: Antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes.
Cross HM, Combrinck MI, Joska JA.
S Afr Med J. 2013 Sep 18;103(10):758-762.
Abstract

Persisting Inflammation and Chronic Immune Activation but Intact Cognitive Function in HIV-infected patients After Long Term Treatment with Combination Antiretroviral Therapy.
Pedersen KK, Pedersen M, Gaardbo JC,  et al
JAcquir Immune Defic Syndr. 2013 Feb .
Abstract

The brain and potent ART: the final frontier?
Powderly W.

J Int AIDS Soc
. 2012 Nov 11;15(6):18175
Abstract

Prolonged treatment with boosted protease inhibitor monotherapy is not associated with a higher rate of neurocognitive impairment than triple drug ART.
Pérez-Valero I, González-Baeza A, Estébanez M,  et al
JInt AIDS Soc
. 2012 Nov 11;15(6):18179.
Abstract

Neurocognitive Impact of Antiretroviral Treatment: Thinking Long-Term.
McPhail ME, Robertson KR.
Curr HIV/AIDS Rep
. 2011 Aug 12
Abstract

Brain dysfunction in the era of combination antiretroviral therapy: Implications for the treatment of the aging population of HIV-infected individuals.
Clark US, Cohen RA.
Curr Opin Investig Drugs
. 2010 Aug;11(8):884-900
Abstract

Incident Neuropathy in HIV-Infected Patients on HAART.
Nakamoto BK, McMurtray A, Davis J,  et al

AIDS Res Hum Retroviruses
. 2010 Jul 12
Abstract

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy.
Canestri A, Lescure FX, Jaureguiberry S, et al 
Clin Infect Dis
. 2010 Jan 25.
Abstract

Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy.
Cardenas V, Meyerhoff D, Studholme C, et al
J Neurovirol. 2009 Jun 4:1-10.
Abstract

HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/microl at the time of
liver biopsy.
Pascual-Pareja JF, Caminoa A, Larrauri C, et al

AIDS
. 2009 May 15;23(8):971-5
Abstract

Cerebrovascular Ischemic Events in HIV-1-Infected Patients Receiving Highly Active Antiretroviral Therapy: Incidence and Risk Factors.
Corral I, Quereda C, Moreno A, et al

Cerebrovasc Dis
. 2009 Apr 24;27(6):559-563.
Abstract

Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
Robinson-Papp J, Byrd D, Mindt MR, et al

Arch Neurol.
2008 Aug;65(8):1096-101.
Abstract


Oral Disorders
       

Journal Papers, Abstracts, and Commentaries

 
Antiretroviral Drug-Associated Oral Lichenoid Reaction in HIV Patient: A Case Report.
Arirachakaran P, Hanvanich M, Kuysakorn P, Thongprasom K.

Int J Dent
. 2010;2010:291072
Abstract

Effects of long-term use of HAART on oral health status of HIV-infected subjects.
Nittayananta W, Talungchit S, Jaruratanasirikul S, et al
 
J Oral Pathol Med
. 2010 Feb 22.
Abstract


Pancreatic Disorders
       

          Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.
Neuman MG, Schneider M, Nanau RM, Parry C.
Int J Hepatol. 2012;2012:760706.

Paper

Autoimmune Disease
       

Graves' Disease (Thyroid Eye Disease)

          Journal Papers, Abstracts, and Commentaries

  Clinical Challenges of Thyroid Eye Disease in HIV Positive Patients on Highly Active Antiretroviral Therapy.
Edmunds MR, Mellington F, Ford RL, et al

J Clin Endocrinol Metab
. 2015 Jan 13:jc20143544
Abstract

Gastrointestinal Disorders
       

          Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
I
mpact of early cART in the gut during acute HIV infection.
Deleage C, Schuetz A, Alvord WG, et al
JCI Insight. 2016 Jul 7;1(10).
.
Paper

Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically-suppressive cART.
Tincati C, Merlini E, Braidotti P,  et al
AIDS
. 2016 Jan 8.
Abstract

HAART toxicity masquerading as a surgical abdomen.
Feghali A, Wang Y, Irizarry E, Lueders M.
Int J Surg Case Rep. 2015 Dec 3;18:33-36.
Abstract

FULL-TEXT ARTICLE
HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.
Neuman MG, Schneider M, Nanau RM, Parry C.
Int J Hepatol. 2012;2012:760706.

Paper


Genitourinary Disorders
       

General Miscellaneous Disorders

       Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT  ARTICLE
Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women.
Kim SC, Messing S, Shah K, Luque AE.
Infect Dis Obstet Gynecol. 2013;2013:784718.

Paper

 

Testicular Disorders
 
       Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy.
Gomes AR, Souteiro P, Silva CG,  et al
BMC Infect Dis
. 2016 Nov 3;16(1):628.
Paper

Renal Disorders

       Journal Papers, Abstracts, and Commentaries
 

 
FULL-TEXT ARTICLE
Renal Function in Chinese HIV-Positive Individuals following Initiation of Antiretroviral Therapy
Zhao Y, Zhang M, Shi CX,  et al

PLoS One
. 2015 Aug 28;10(8):e0135462.
Paper

Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort.
da Rocha IM, Gasparotto AS, Lazzaretti RK,  et al
Pharmacogenet Genomics. 2015 Aug 18. |
Abstract

Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Achhra A, Mocroft A, Ross M, et al
HIV Med
. 2015 Apr;16 Suppl 1:55-63.
Abstract

Albuminuria is associated with elevated acute phase reactants and proinflammatory markers in HIV-infected patients receiving suppressive combination antiretroviral therapy.
O-Charoen P, Ndhlovu L, Gangcuangco LM, et al

AIDS Res Hum Retroviruses
. 2014 Sep
9.
Abstract

Renal toxicity associated with antiretroviral therapy.
Calza L.

HIV Clin Trials
. 2012 Jul-Aug;13(4):189-211
Abstract

Nephrotoxicity of HAART.
Kalyesubula R, Perazella MA.
AIDS Res Treat. 2011;2011
.
Abstract

Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
Bigé N, Lanternier F, Viard JP, Kamgang P,  et al
Nephrol Dial Transplant
. 2011 Jul
Abstract

Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy.
Dauchy FA, Lawson-Ayayi S, de La Faille R, et al

Kidney Int
. 2011 May 4. .
Abstract

Renal Disease Associated with Antiretroviral Therapy in the Treatment of HIV.
Cooper RD, Tonelli M.

Nephron Clin Pract
. 2011 Jan 4;118(3):c263-c269
Abstract

The Impact of Kidney Function at Highly Active Antiretroviral Therapy Initiation on Mortality in HIV-Infected Women.
Estrella MM, Parekh RS, Abraham A,  et al
 
J Acquir Immune Defic Syndr
. 2010 Jun 25
Abstract

Antiretroviral medications: adverse effects on the kidney.
Jao J, Wyatt CM.

Adv Chronic Kidney Dis
. 2010 Jan;17(1):72-82.
Abstract

 

Respiratory
       

       Journal Papers, Abstracts, and Commentaries
 
 
The Impact of Antiretroviral Therapy on Lung Immunology.
Cribbs SK, Fontenot AP.
Semin Respir Crit Care Med
. 2016 Apr;37(2):157-165.
Abstract

Pulmonary function in an international sample of HIV-positive, treatment-naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Kunisaki K, Niewoehner, Collins G, et al  
HIV Med
. 2015 Apr;16 Suppl S1:119-128.
Abstract

Will expanded ART use reduce the burden of HIV-associated chronic lung disease?
Kunisaki KM.

Curr Opin HIV AIDS
. 2013 Nov 15.
Abstract

FULL-TEXT ARTICLE
The Impact of HAART on the Respiratory Complications of HIV Infection: Longitudinal Trends in the MACS and WIHS Cohorts.
Gingo MR, Balasubramani GK, Kingsley L, et al
PLoS One. 2013;8(3):e58812.
Paper

Overcoming resistance to existing therapies in HIV-infected patients: The role of new antiretroviral drugs.
Perno CF, Moyle G, Tsoukas C, et al 
J Med Virol.
2008 Feb 22;80(4):565-576

Abstract


HAART Main Page Main New/Newsworthy  Home Page

HAART/ART Adverse Events